Captopril in the treatment of hypertension in type I and type II diabetic patients.
Ten type I and 10 type II hypertensive diabetic patients were treated for 12 weeks with captopril (50 mg twice daily). Good control of blood pressure was achieved without any significant adverse effect on carbohydrate metabolism or renal haemodynamics and without evidence of glomerular or tubular damage.
D000328:Adult; D002216:Captopril / Q000009:adverse effects / Q000627:therapeutic use*; D050260:Carbohydrate Metabolism; D003922:Diabetes Mellitus, Type 1 / Q000150:complications* / Q000503:physiopathology; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000503:physiopathology; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D012079:Renal Circulation / Q000187:drug effects
D002216:Captopril